Telix flies after FDA gives drug tick to product

MELBOURNE: Shares in $1.4 billion biotech Telix Pharmaceuticals have jumped 9.6 per cent ...

To read the full story...SUBSCRIBE NOW

Existing Subscribers Login Below:

Log In